Breaking News Instant updates and real-time market news.

GD

General Dynamics

$179.07 /

-2.23 (-1.23%)

14:25
12/02/19
12/02
14:25
12/02/19
14:25

General Dynamics call volume above normal and directionally bullish

Bullish option flow detected in General Dynamics with 2,260 calls trading, 1.1x expected, and implied vol increasing almost 2 points to 16.70%. 12/6 weekly 180 calls and Dec-19 185 calls are the most active options, with total volume in those strikes near 1,200 contracts. The Put/Call Ratio is 0.28. Earnings are expected on January 29th.

GD General Dynamics
$179.07 /

-2.23 (-1.23%)

10/24/19 Cowen
General Dynamics weakness a buying opportunity, says Cowen
08/20/19 BofA
BofA/Merrill US 1 List changes
07/10/19 Baird
General Dynamics price target raised to $218 from $188 at Baird
05/20/19
Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Hot Stocks
Genocea announces FDA acceptance of GEN-011 IND application » 07:32
09/22/20
09/22
07:32
09/22/20
07:32
GNCA

Genocea

$2.29 /

-0.06 (-2.55%)

Genocea Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GNCA Genocea
$2.29 /

-0.06 (-2.55%)

GNCA Genocea
$2.29 /

-0.06 (-2.55%)

07/30/20 Stifel
Genocea '009 efficacy boding well for more substantial update ahead, says Stifel
07/27/20 Stifel
Stifel recommends Genocea shares ahead of first look at GEN-009 efficacy
07/23/20 H.C. Wainwright
Genocea price target lowered to $9 from $32 at H.C. Wainwright
11/15/19 SVB Leerink
Genocea initiated with an Outperform at SVB Leerink
GNCA Genocea
$2.29 /

-0.06 (-2.55%)

GNCA Genocea
$2.29 /

-0.06 (-2.55%)

Hot Stocks
Frequency Therapeutics completes patient enrollment of FX-322 » 07:32
09/22/20
09/22
07:32
09/22/20
07:32
FREQ

Frequency Therapeutics

$24.22 /

-0.54 (-2.18%)

Frequency Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FREQ Frequency Therapeutics
$24.22 /

-0.54 (-2.18%)

FREQ Frequency Therapeutics
$24.22 /

-0.54 (-2.18%)

07/13/20 Oppenheimer
Frequency Therapeutics initiated with an Outperform at Oppenheimer
05/18/20 JPMorgan
JPMorgan downgrades Frequency Therapeutics on unclear data timelines
05/18/20 JPMorgan
Frequency Therapeutics downgraded to Neutral from Overweight at JPMorgan
10/28/19 JPMorgan
Frequency Therapeutics initiated with an Overweight at JPMorgan
FREQ Frequency Therapeutics
$24.22 /

-0.54 (-2.18%)

  • 03
    Oct
FREQ Frequency Therapeutics
$24.22 /

-0.54 (-2.18%)

FREQ Frequency Therapeutics
$24.22 /

-0.54 (-2.18%)

Hot Stocks
Vaccinex says Phase 2 SIGNAL study does not meet co-primary endpoints » 07:31
09/22/20
09/22
07:31
09/22/20
07:31
VCNX

Vaccinex

$5.49 /

-0.16 (-2.83%)

Vaccinex announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VCNX Vaccinex
$5.49 /

-0.16 (-2.83%)

VCNX Vaccinex
$5.49 /

-0.16 (-2.83%)

VCNX Vaccinex
$5.49 /

-0.16 (-2.83%)

VCNX Vaccinex
$5.49 /

-0.16 (-2.83%)

Recommendations
Susquehanna updates estimates for Western Digital and Seagate » 07:31
09/22/20
09/22
07:31
09/22/20
07:31
WDC

Western Digital

$36.10 /

-1.12 (-3.01%)

, STX

Seagate

$46.94 /

-0.57 (-1.20%)

Susquehanna analyst Mehdi…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WDC Western Digital
$36.10 /

-1.12 (-3.01%)

STX Seagate
$46.94 /

-0.57 (-1.20%)

WDC Western Digital
$36.10 /

-1.12 (-3.01%)

09/20/20 Deutsche Bank
Western Digital named short-term buy idea at Deutsche Bank
08/12/20 Deutsche Bank
Micron downgraded to Hold from Buy at Deutsche Bank
08/06/20
Fly Intel: Top five analyst downgrades
08/06/20 Craig-Hallum
Western Digital downgraded to Hold at Craig-Hallum
STX Seagate
$46.94 /

-0.57 (-1.20%)

09/15/20 Northland
Seagate initiated with an Outperform at Northland
09/08/20 Wells Fargo
Seagate provides positive comments on current quarter trends, says Wells Fargo
08/31/20 Morgan Stanley
Seagate shows confidence in above-consensus FY21 view, says Morgan Stanley
08/04/20
Fly Intel: Top five analyst upgrades
WDC Western Digital
$36.10 /

-1.12 (-3.01%)

STX Seagate
$46.94 /

-0.57 (-1.20%)

WDC Western Digital
$36.10 /

-1.12 (-3.01%)

STX Seagate
$46.94 /

-0.57 (-1.20%)

WDC Western Digital
$36.10 /

-1.12 (-3.01%)

STX Seagate
$46.94 /

-0.57 (-1.20%)

WDC Western Digital
$36.10 /

-1.12 (-3.01%)

STX Seagate
$46.94 /

-0.57 (-1.20%)

Upgrade
WPX Energy upgraded to Buy from Hold at Truist » 07:29
09/22/20
09/22
07:29
09/22/20
07:29
WPX

WPX Energy

$4.51 /

-0.27 (-5.65%)

Truist analyst Neal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WPX WPX Energy
$4.51 /

-0.27 (-5.65%)

WPX WPX Energy
$4.51 /

-0.27 (-5.65%)

05:18 Today Truist
WPX Energy upgraded to Buy from Hold at Truist
09/14/20 Northland
WPX Energy downgraded to Market Perform from Outperform at Northland
07/27/20 Seaport Global
WPX Energy initiated with a Neutral at Seaport Global
07/20/20 Northland
WPX Energy price target raised to $7.50 from $7 at Northland
WPX WPX Energy
$4.51 /

-0.27 (-5.65%)

WPX WPX Energy
$4.51 /

-0.27 (-5.65%)

WPX WPX Energy
$4.51 /

-0.27 (-5.65%)

Recommendations
Semi cap pullback an attractive entry point in Applied Materials, says Stifel » 07:28
09/22/20
09/22
07:28
09/22/20
07:28
AMAT

Applied Materials

$57.33 /

+1.17 (+2.08%)

Stifel analyst Patrick Ho…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

08/17/20 Citi
Applied Materials price target raised to $75 from $62 at Citi
08/14/20 DA Davidson
Applied Materials price target raised to $70 from $55 at DA Davidson
08/14/20 B. Riley FBR
Applied Materials price target raised to $82 from $72 at B. Riley FBR
08/14/20 Craig-Hallum
Applied Materials price target raised to $83 from $79 at Craig-Hallum
AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

AMAT Applied Materials
$57.33 /

+1.17 (+2.08%)

Recommendations
Rocket Pharmaceuticals price target lowered to $33 from $43 at Oppenheimer » 07:27
09/22/20
09/22
07:27
09/22/20
07:27
RCKT

Rocket Pharmaceuticals

$23.82 /

-2.1 (-8.10%)

Oppenheimer analyst Kevin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCKT Rocket Pharmaceuticals
$23.82 /

-2.1 (-8.10%)

RCKT Rocket Pharmaceuticals
$23.82 /

-2.1 (-8.10%)

09/10/20 SMBC Nikko
Rocket Pharmaceuticals initiated with an Outperform at SMBC Nikko
08/05/20 Piper Sandler
Rocket readouts should create 'substantial value,' says Piper Sandler
07/21/20 Piper Sandler
Rocket shares should be owned through year-end, says Piper Sandler
07/02/20 JPMorgan
Rocket Pharmaceuticals initiated with an Overweight at JPMorgan
RCKT Rocket Pharmaceuticals
$23.82 /

-2.1 (-8.10%)

  • 11
    Dec
Upgrade
Matador upgraded to Buy from Hold at Truist » 07:25
09/22/20
09/22
07:25
09/22/20
07:25
MTDR

Matador

$8.55 /

-0.3 (-3.39%)

Truist analyst Neal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTDR Matador
$8.55 /

-0.3 (-3.39%)

MTDR Matador
$8.55 /

-0.3 (-3.39%)

05:11 Today Truist
Matador upgraded to Buy from Hold at Truist
09/14/20 Wells Fargo
Matador upgraded to Overweight from Equal Weight at Wells Fargo
07/29/20 Northland
Matador guidance seems conservative after 'big beat' in Q2, says Northland
07/23/20
Fly Intel: Top five analyst downgrades
MTDR Matador
$8.55 /

-0.3 (-3.39%)

MTDR Matador
$8.55 /

-0.3 (-3.39%)

MTDR Matador
$8.55 /

-0.3 (-3.39%)

Conference/Events
Blucora participates in a conference call with Benchmark » 07:25
09/22/20
09/22
07:25
09/22/20
07:25
BCOR

Blucora

$9.04 /

+0.06 (+0.67%)

Services Analyst Kurnos…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCOR Blucora
$9.04 /

+0.06 (+0.67%)

BCOR Blucora
$9.04 /

+0.06 (+0.67%)

08/05/20 Barrington
Blucora price target lowered to $15 from $18 at Barrington
02/19/20 William Blair
Blucora shares will require patience, says William Blair
01/16/20 Barrington
Blucora selloff on CEO departure a buying opportunity, says Barrington
01/13/20 JPMorgan
Blucora downgraded to Neutral from Overweight on deal risks at JPMorgan
BCOR Blucora
$9.04 /

+0.06 (+0.67%)

Recommendations
Seattle Genetics price target raised to $165 from $145 at Stifel » 07:24
09/22/20
09/22
07:24
09/22/20
07:24
SGEN

Seattle Genetics

/

+

, MRK

Merck

$83.11 /

-2.71 (-3.16%)

Stifel analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGEN Seattle Genetics
/

+

MRK Merck
$83.11 /

-2.71 (-3.16%)

SGEN Seattle Genetics
/

+

06:11 Today JMP Securities
Seattle Genetics price target raised to $200 from $185 at JMP Securities
09/21/20 Piper Sandler
Tisotumab data sets Seattle Genetics up for another approval, says Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
MRK Merck
$83.11 /

-2.71 (-3.16%)

09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/14/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
09/14/20 Piper Sandler
Seattle Genetics price target raised to $172 from $165 at Piper Sandler
SGEN Seattle Genetics
/

+

MRK Merck
$83.11 /

-2.71 (-3.16%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

SGEN Seattle Genetics
/

+

MRK Merck
$83.11 /

-2.71 (-3.16%)

MRK Merck
$83.11 /

-2.71 (-3.16%)

Recommendations
Aurora Cannabis price target lowered to C$10 from C$21 at Canaccord » 07:24
09/22/20
09/22
07:24
09/22/20
07:24
ACB

Aurora Cannabis

$6.33 /

-0.2 (-3.06%)

Canaccord analyst Matt…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

09/21/20 Jefferies
Jefferies upgrades Aurora Cannabis to Hold, cuts price target to C$8.70
09/21/20 Jefferies
Aurora Cannabis upgraded to Hold from Underperform at Jefferies
09/09/20 Stifel
Aurora Cannabis price target lowered to C$10.50 from C$16 at Stifel
09/09/20 Cantor Fitzgerald
Aurora Cannabis price target lowered to C$17.50 from C$29 at Cantor Fitzgerald
ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

ACB Aurora Cannabis
$6.33 /

-0.2 (-3.06%)

Recommendations
Accenture price target raised to $255 from $240 at Wedbush » 07:21
09/22/20
09/22
07:21
09/22/20
07:21
ACN

Accenture

$233.94 /

-2.17 (-0.92%)

Wedbush analyst Moshe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

06:08 Today Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
09/21/20 Barclays
Accenture price target raised to $260 from $240 at Barclays
09/20/20 Citi
Accenture price target raised to $269 from $247 at Citi
ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

Hot Stocks
Lexaria Bioscience granted DehydraTECH technology patent from USPTO » 07:21
09/22/20
09/22
07:21
09/22/20
07:21
LXRP

Lexaria Bioscience

$0.00 /

+ (+0.00%)

Lexaria Bioscience…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LXRP Lexaria Bioscience
$0.00 /

+ (+0.00%)

Recommendations
Cubic strategy validated by Elliott stake, says Canaccord » 07:21
09/22/20
09/22
07:21
09/22/20
07:21
CUB

Cubic

$59.56 /

+15.18 (+34.20%)

Canaccord analyst Ken…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CUB Cubic
$59.56 /

+15.18 (+34.20%)

CUB Cubic
$59.56 /

+15.18 (+34.20%)

06:46 Today RBC Capital
Cubic price target raised to $52 from $48 at RBC Capital
09/21/20 Citi
Elliott's interest in Cubic supportive of underlying value, says Citi
09/16/20 Citi
Cubic price target raised to $60 from $50 at Citi
09/15/20 JPMorgan
Cubic price target raised to $61 from $56 at JPMorgan
CUB Cubic
$59.56 /

+15.18 (+34.20%)

CUB Cubic
$59.56 /

+15.18 (+34.20%)

CUB Cubic
$59.56 /

+15.18 (+34.20%)

Recommendations
Morgan Stanley says Cree poised to benefit from investments in EV, clean energy » 07:20
09/22/20
09/22
07:20
09/22/20
07:20
CREE

Cree

$58.35 /

-3.97 (-6.37%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CREE Cree
$58.35 /

-3.97 (-6.37%)

09/04/20 Canaccord
Cree design wins add $1B market opportunity, says Canaccord
08/20/20 Citi
Cree price target lowered to $71 from $82 at Citi
08/19/20 Roth Capital
Cree downgraded to Neutral from Buy at Roth Capital
08/19/20 Wells Fargo
Cree price target raised to $65 from $45 at Wells Fargo
CREE Cree
$58.35 /

-3.97 (-6.37%)

CREE Cree
$58.35 /

-3.97 (-6.37%)

CREE Cree
$58.35 /

-3.97 (-6.37%)

CREE Cree
$58.35 /

-3.97 (-6.37%)

Recommendations
Illumina price target lowered to $300 from $350 at Canaccord » 07:16
09/22/20
09/22
07:16
09/22/20
07:16
ILMN

Illumina

$269.60 /

-25.695 (-8.70%)

Canaccord analyst Max…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

07:07 Today Baird
Illumina price target lowered to $281 from $335 at Baird
06:17 Today Citi
Illumina acquisition 'adds ambiguity' around valuation, says Citi
06:08 Today UBS
Illumina downgraded to Neutral from Buy at UBS
06:00 Today Stifel
Stifel downgrades Illumina to Hold after 'massively dilutive' deal
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

Hot Stocks
AutoZone up 5.4% to $1,250 after Q4 results beat estimates  07:14
09/22/20
09/22
07:14
09/22/20
07:14
AZO

AutoZone

$1,181.71 /

-22.41 (-1.86%)

 
ShowHide Related Items >><<
AZO AutoZone
$1,181.71 /

-22.41 (-1.86%)

AZO AutoZone
$1,181.71 /

-22.41 (-1.86%)

09/18/20 DA Davidson
AutoZone expected to outperform Q4 consensus estimates, says DA Davidson
09/17/20 Morgan Stanley
AutoZone price target raised to $1,505 from $1,140 at Morgan Stanley
09/14/20 Wells Fargo
AutoZone price target raised to $1,375 from $1,300 at Wells Fargo
09/08/20 Atlantic Equities
AutoZone upgraded to Overweight from Neutral at Atlantic Equities
AZO AutoZone
$1,181.71 /

-22.41 (-1.86%)

Hot Stocks
AIM ImmunoTech announces pancreatic cancer survival results from EAP » 07:14
09/22/20
09/22
07:14
09/22/20
07:14
AIM

AIM ImmunoTech

$2.05 /

-0.03 (-1.44%)

AIM ImmunoTech announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

04/06/20 Maxim
AIM ImmunoTech price target raised to $5 from $2 at Maxim
10/10/19 Maxim
AIM ImmunoTech has removed financing overhang, says Maxim
10/10/19 Maxim
AIM ImmunoTech upgraded to Buy from Hold at Maxim
AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

AIM AIM ImmunoTech
$2.05 /

-0.03 (-1.44%)

Recommendations
Sykes Enterprises desiganted as a Fresh Pick at Baird » 07:13
09/22/20
09/22
07:13
09/22/20
07:13
SYKE

Sykes Enterprises

$31.55 /

-1.5 (-4.54%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYKE Sykes Enterprises
$31.55 /

-1.5 (-4.54%)

06/04/20 Baird
Sykes Enterprises upgraded to Outperform at Baird
06/04/20 Baird
Sykes Enterprises upgraded to Outperform from Neutral at Baird
03/16/20 Sidoti
Sykes Enterprises upgraded to Buy from Neutral at Sidoti
11/11/19 Sidoti
Sykes Enterprises downgraded to Neutral on valuation at Sidoti
SYKE Sykes Enterprises
$31.55 /

-1.5 (-4.54%)

SYKE Sykes Enterprises
$31.55 /

-1.5 (-4.54%)

Hot Stocks
LiveXLive Media announces expansion in Latin America » 07:13
09/22/20
09/22
07:13
09/22/20
07:13
LIVX

LiveXLive Media

$2.78 /

-0.23 (-7.64%)

LiveXLive Media announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

08/07/20 H.C. Wainwright
LiveXLive Media price target raised to $6 from $4.50 at H.C. Wainwright
06/19/20 Alliance Global Partners
LiveXLive Media price target raised to $6 from $5.50 at Alliance Global Partners
06/19/20 Ladenburg
LiveXLive Media price target raised to $5.75 from $4.50 at Ladenburg
05/11/20 Alliance Global Partners
LiveXLive Media price target raised to $5.50 from $4 at Alliance Global Partners
LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

LIVX LiveXLive Media
$2.78 /

-0.23 (-7.64%)

Recommendations
PPD, Inc. price target raised to $38 from $35 at Mizuho » 07:13
09/22/20
09/22
07:13
09/22/20
07:13
PPD

PPD, Inc.

$34.14 /

+0.29 (+0.86%)

Mizuho analyst Ann Hynes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

09/21/20 Baird
PPD, Inc. price target raised to $40 from $36 at Baird
08/06/20 Mizuho
PPD, Inc. price target raised to $35 from $29 at Mizuho
08/06/20 Citi
PPD, Inc. price target raised to $37 from $31 at Citi
08/05/20 Credit Suisse
PPD, Inc. price target raised to $35 from $30 at Credit Suisse
PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

  • 17
    Sep
  • 06
    Feb
PPD PPD, Inc.
$34.14 /

+0.29 (+0.86%)

Recommendations
Wave Life recent volatility not due to fundamentals, says Mizuho » 07:11
09/22/20
09/22
07:11
09/22/20
07:11
WVE

Wave Life Sciences

$15.02 /

-4.6 (-23.45%)

Mizuho analyst Salim Syed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

02/07/20 Guggenheim
Guggenheim starts NeuBase Therapeutics at Buy with $13 price target
01/02/20 H.C. Wainwright
H.C. Wainwright cuts Wave Life price target to $20, but 'not throwing in towel'
12/31/19
Fly Intel: Top five analyst actions
12/31/19 Guggenheim
Wave Huntington's data 'mediocre, but not a zero,' says Guggenheim
WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

WVE Wave Life Sciences
$15.02 /

-4.6 (-23.45%)

Hot Stocks
UCB: FDA, EMA accept BLA, MAA for bimekizumab » 07:11
09/22/20
09/22
07:11
09/22/20
07:11
UCBJY

UCB

$0.00 /

+ (+0.00%)

UCB announced that the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
UCBJY UCB
$0.00 /

+ (+0.00%)

07/31/20 UBS
UCB downgraded to Neutral from Buy at UBS
07/28/20 JPMorgan
UCB price target raised to EUR 124 from EUR 114 at JPMorgan
06/15/20 Oddo BHF
UCB upgraded to Buy from Neutral at Oddo BHF
05/18/20 Jefferies
Jefferies names Beazley, Ferguson, Novartis, Rio Tinto high conviction ideas
Earnings
CoreLogic raises FY21 revenue view to $1.97B-$2.01B from $1.91B-$1.95B » 07:10
09/22/20
09/22
07:10
09/22/20
07:10
CLGX

CoreLogic

$67.54 /

+0.23 (+0.34%)

Consensus $1.88B. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

07/24/20
Fly Intel: Top five analyst downgrades
07/24/20 Stephens
Stephens sees limited further upside for CoreLogic shares, cuts to Equal Weight
07/24/20 Stephens
CoreLogic downgraded to Equal Weight from Overweight at Stephens
07/24/20 Compass Point
CoreLogic downgraded to Neutral from Buy at Compass Point
CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

CLGX CoreLogic
$67.54 /

+0.23 (+0.34%)

Initiation
Aldeyra initiated with a Buy at Alliance Global Partners » 07:10
09/22/20
09/22
07:10
09/22/20
07:10
ALDX

Aldeyra

$6.97 /

-0.44 (-5.94%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

06/04/20 JonesTrading
Aldeyra pact with FDA may point to 'surer path' for approval, says JonesTrading
05/11/20 Oppenheimer
Aldeyra initiated with an Outperform at Oppenheimer
12/03/19 JonesTrading
Aldeyra dry eye data positive nearly across the board, says JonesTrading
10/22/19 Cantor Fitzgerald
Aldeyra assumed with an Overweight at Cantor Fitzgerald
ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

ALDX Aldeyra
$6.97 /

-0.44 (-5.94%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.